summary
Introduced
01/25/2021
01/25/2021
In Committee
01/28/2021
01/28/2021
Crossed Over
Passed
Dead
04/30/2021
04/30/2021
Introduced Session
2021 Regular Session
Bill Summary
Defining the term "prescription insulin drug"; requiring individual and group health insurance policies, respectively, to cap an insured's monthly cost-sharing obligation for covered prescription insulin drugs at a specified amount; providing that coverage for prescription insulin drugs may not be subject to a deductible, etc.
AI Summary
This bill defines the term "prescription insulin drug" and requires individual and group health insurance policies, as well as health maintenance contracts, to cap an insured's monthly cost-sharing obligation for covered prescription insulin drugs at $100 per 30-day supply, regardless of the amount or type of insulin needed. The bill also specifies that coverage for prescription insulin drugs may not be subject to a deductible, and it authorizes the commission to adopt rules to administer these provisions. The bill will take effect on January 1, 2022.
Committee Categories
Budget and Finance, Business and Industry
Sponsors (3)
Last Action
Died in Appropriations Subcommittee on Health and Human Services (on 04/30/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.flsenate.gov/Session/Bill/2021/786 |
| Analysis - Banking and Insurance (Post-Meeting) | https://www.flsenate.gov/Session/Bill/2021/786/Analyses/2021s00786.bi.PDF |
| Analysis - Banking and Insurance (Pre-Meeting) | https://www.flsenate.gov/Session/Bill/2021/786/Analyses/2021s00786.pre.bi.PDF |
| BillText | https://www.flsenate.gov/Session/Bill/2021/786/BillText/Filed/HTML |
| Bill | https://www.flsenate.gov/Session/Bill/2021/786/BillText/Filed/PDF |
Loading...